Thermo Fisher Scientific (NYSE:TMO) stock gains as company beats Q2 2025 forecasts with $10.9B revenue, driven by Life ...

Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating ...

Thermo Fisher Scientific posted better-than-expected profit and revenue in its latest quarter.

Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy now. On July 16, Thermo ...

While midazolam is the only sedative labeled for continuous use during mechanical ventilation in pediatric ICU patients, ...

Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.

Tokuyama and OCI TerraSus have established a joint venture for the production and sale of semiconductor-grade polycrystalline ...

Thermo Fisher is acquiring Sanofi’s Ridgefield, NJ sterile drug plant, transferring 200 employees to bolster U.S. fill‑finish ...